The 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitor Lovastatin Reduces Severity of l-DOPA-Induced Abnormal Involuntary Movements in Experimental Parkinson's DiseaseStefan Schuster, Erwan Bézard|Journal of Neuroscience|2008Cited by 87